Tiny tablet, big hope: new PKU supplement put to the test

NCT ID NCT06694662

Completed Disease control Sponsor: Galen Limited Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tested a new microtablet supplement called PKU EASY Microtabs Plus in 10 people with PKU aged 3 and older. The supplement is a slow-release protein substitute designed to help manage PKU. Over one week, researchers checked how well participants tolerated it (stomach issues), how much they actually took, and whether they liked the taste and texture. It's a small, early-stage study focused on acceptability, not on long-term disease control.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: PKU EASY Microtabs Plus (a slow-release, phenylalanine-free protein substitute with amino acids, vitamins, and minerals)
What this could lead to: If successful, this could provide a more convenient and tolerable dietary supplement option for people with PKU.
What could go wrong: This is a very small, short-term study (10 participants, 1 week) focused only on acceptability and tolerance, not on long-term health outcomes. Results may not apply to all PKU patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PHENYLKETONURIA (PKU) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

phenylketonuria

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PHENYLKETONURIA (PKU)

Contacts and locations

Locations

Birmingham Children's Hospital

Birmingham, UK, B4 6NH, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.